Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "manufacturers"

342 News Found

Syntegon acquires Telstar
Packaging | June 09, 2024

Syntegon acquires Telstar

Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth


Zydus launches Mirabegron ER Tablets in the US
Drug Approval | April 22, 2024

Zydus launches Mirabegron ER Tablets in the US

Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market


Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences
News | March 28, 2024

Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences

Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%


Johnson Matthey sells Medical Device Components business for US$700 million to Montagu
Medical Device | March 21, 2024

Johnson Matthey sells Medical Device Components business for US$700 million to Montagu

The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol


Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
Policy | March 07, 2024

Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme

The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics


Tritan used for safer medical infusion therapy
Medical Device | January 17, 2024

Tritan used for safer medical infusion therapy

This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device


Strides Pharma Science to invest in AMP-6, AMP-8
News | January 03, 2024

Strides Pharma Science to invest in AMP-6, AMP-8

AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka


Norms for fixing prices of medicines
Policy | December 20, 2023

Norms for fixing prices of medicines

NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201